Engineers Gate Manager LP Sage Therapeutics, Inc. Transaction History
Engineers Gate Manager LP
- $7.46 Billion
- Q2 2025
A detailed history of Engineers Gate Manager LP transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Engineers Gate Manager LP holds 10,868 shares of SAGE stock, worth $94,334. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,868
Previous 42,447
74.4%
Holding current value
$94,334
Previous $337,000
70.62%
% of portfolio
0.0%
Previous 0.01%
Shares
18 transactions
Others Institutions Holding SAGE
# of Institutions
204Shares Held
50MCall Options Held
790KPut Options Held
440K-
Madison Avenue Partners, LP New York, NY6.08MShares$52.7 Million5.93% of portfolio
-
Black Rock Inc. New York, NY5.22MShares$45.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.27MShares$28.3 Million0.0% of portfolio
-
Hudson Bay Capital Management LP Greenwich, CT1.95MShares$16.9 Million0.07% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY1.92MShares$16.6 Million0.01% of portfolio
About Sage Therapeutics, Inc.
- Ticker SAGE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,422,300
- Market Cap $516M
- Description
- Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...